China · Delayed Price · Currency is CNY Sinocare Statistics
Total Valuation
Sinocare has a market cap or net worth of CNY 9.94 billion. The enterprise value is 10.10 billion.
| Market Cap | 9.94B |
| Enterprise Value | 10.10B |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Sinocare has 554.14 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 554.14M |
| Shares Outstanding | 554.14M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | -0.83% |
| Owned by Insiders (%) | 49.69% |
| Owned by Institutions (%) | 22.06% |
| Float | 273.28M |
Valuation Ratios
The trailing PE ratio is 35.08 and the forward PE ratio is 23.14. Sinocare's PEG ratio is 0.93.
| PE Ratio | 35.08 |
| Forward PE | 23.14 |
| PS Ratio | 2.11 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 5.08 |
| P/FCF Ratio | 16.87 |
| P/OCF Ratio | 12.98 |
| PEG Ratio | 0.93 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.30, with an EV/FCF ratio of 17.15.
| EV / Earnings | 35.82 |
| EV / Sales | 2.14 |
| EV / EBITDA | 21.30 |
| EV / EBIT | 36.93 |
| EV / FCF | 17.15 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.43 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | 1.50 |
| Interest Coverage | 6.79 |
Financial Efficiency
Return on equity (ROE) is 6.26% and return on invested capital (ROIC) is 6.43%.
| Return on Equity (ROE) | 6.26% |
| Return on Assets (ROA) | 2.81% |
| Return on Invested Capital (ROIC) | 6.43% |
| Return on Capital Employed (ROCE) | 6.17% |
| Weighted Average Cost of Capital (WACC) | 3.04% |
| Revenue Per Employee | 980,317 |
| Profits Per Employee | 58,630 |
| Employee Count | 5,014 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.27 |
Taxes
In the past 12 months, Sinocare has paid 40.46 million in taxes.
| Income Tax | 40.46M |
| Effective Tax Rate | 15.13% |
Stock Price Statistics
The stock price has decreased by -23.15% in the last 52 weeks. The beta is -0.23, so Sinocare's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -23.15% |
| 50-Day Moving Average | 17.85 |
| 200-Day Moving Average | 19.98 |
| Relative Strength Index (RSI) | 46.17 |
| Average Volume (20 Days) | 8,509,663 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinocare had revenue of CNY 4.71 billion and earned 281.95 million in profits. Earnings per share was 0.51.
| Revenue | 4.71B |
| Gross Profit | 2.38B |
| Operating Income | 273.50M |
| Pretax Income | 267.43M |
| Net Income | 281.95M |
| EBITDA | 458.98M |
| EBIT | 273.50M |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
The company has 1.07 billion in cash and 881.81 million in debt, with a net cash position of 190.41 million or 0.34 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 881.81M |
| Net Cash | 190.41M |
| Net Cash Per Share | 0.34 |
| Equity (Book Value) | 3.67B |
| Book Value Per Share | 5.99 |
| Working Capital | 770.33M |
Cash Flow
In the last 12 months, operating cash flow was 765.35 million and capital expenditures -176.39 million, giving a free cash flow of 588.96 million.
| Operating Cash Flow | 765.35M |
| Capital Expenditures | -176.39M |
| Free Cash Flow | 588.96M |
| FCF Per Share | 1.06 |
Margins
Gross margin is 50.54%, with operating and profit margins of 5.80% and 5.98%.
| Gross Margin | 50.54% |
| Operating Margin | 5.80% |
| Pretax Margin | 5.67% |
| Profit Margin | 5.98% |
| EBITDA Margin | 9.74% |
| EBIT Margin | 5.80% |
| FCF Margin | 12.49% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.20%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 1.20% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 47.92% |
| Buyback Yield | 0.59% |
| Shareholder Yield | 1.77% |
| Earnings Yield | 2.84% |
| FCF Yield | 5.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 16, 2018. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 16, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Sinocare has an Altman Z-Score of 4.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.45 |
| Piotroski F-Score | 6 |